% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Thummerer:177262,
author = {A. Thummerer and C. S. Oria and P. Zaffino and A. Meijers
and G. G. Marmitt and R. Wijsman and J. Seco$^*$ and J. A.
Langendijk and A.-C. Knopf and M. F. Spadea and S. Both},
title = {{C}linical suitability of deep learning based synthetic
{CT}s for adaptive proton therapy of lung cancer.},
journal = {Medical physics},
volume = {48},
number = {12},
issn = {2473-4209},
address = {College Park, Md.},
publisher = {AAPM},
reportid = {DKFZ-2021-02395},
pages = {7673-7684},
year = {2021},
note = {2021 Dec;48(12):7673-7684},
abstract = {Adaptive proton therapy (APT) of lung cancer patients
requires frequent volumetric imaging of diagnostic quality.
Cone-beam CT (CBCT) can provide these daily images, but
x-ray scattering limits CBCT-image quality and hampers dose
calculation accuracy. The purpose of this study was to
generate CBCT-based synthetic CTs using a deep convolutional
neural network (DCNN) and investigate image quality and
clinical suitability for proton dose calculations in lung
cancer patients.A dataset of 33 thoracic cancer patients,
containing CBCTs, same-day repeat CTs (rCT), planning-CTs
(pCTs) and clinical proton treatment plans, was used to
train and evaluate a DCNN with and without a pCT-based
correction method. Mean absolute error (MAE), mean error
(ME), peak signal-to-noise ratio and structural similarity
were used to quantify image quality. The evaluation of
clinical suitability was based on recalculation of clinical
proton treatment plans. Gamma pass ratios, mean dose to
target volumes and organs at risk, and normal tissue
complication probabilities (NTCP) were calculated.
Furthermore, proton radiography simulations were performed
to assess the HU-accuracy of sCTs in terms of range
errors.On average, sCTs without correction resulted in a MAE
of 34±6 HU and ME of 4±8 HU. The correction reduced the
MAE to 31±4HU (ME to 2±4HU). Average $3\%/3mm$ gamma pass
ratios increased from $93.7\%$ to $96.8\%,$ when the
correction was applied. The patient specific correction
reduced mean proton range errors from 1.5 to 1.1 mm.
Relative mean target dose differences between sCTs and rCT
were below $±0.5\%$ for all patients and both synthetic CTs
(with/without correction). NTCP values showed high agreement
between sCTs and rCT $(<2\%).CBCT-based$ sCTs can enable
accurate proton dose calculations for APT of lung cancer
patients. The patient specific correction method increased
the image quality and dosimetric accuracy but had only a
limited influence on clinically relevant parameters. This
article is protected by copyright. All rights reserved.},
keywords = {CBCT (Other) / Deep learning (Other) / adaptive proton
therapy (Other) / lung cancer (Other) / synthetic CT
(Other)},
cin = {E041},
ddc = {610},
cid = {I:(DE-He78)E041-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34725829},
doi = {10.1002/mp.15333},
url = {https://inrepo02.dkfz.de/record/177262},
}